AlphaFold predicted structure
ENO3 · P13929

Mean pLDDT
97.6/ 100
Very high
434 residues
Confidence breakdown
- Very high(≥ 90)98%
- Confident(70–90)2%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
enolase 3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Hyperammonaemia
Ketotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalglycogen storage disease due to muscle beta-enolase deficiency
neurodegenerative disease
Exercise-induced rhabdomyolysis
Thrombocytopenia
hereditary disease
amyotrophic lateral sclerosis
kidney disorder
hepatocellular carcinoma
metabolic dysfunction-associated steatohepatitis
malignant colon neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Beta-enolase
Enolase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis and the reverse reaction in gluconeogenesis. Appears to have a function in striated muscle development and regeneration
ENO3 · P13929

Mean pLDDT
97.6/ 100
Very high
434 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0